Previous 10 | Next 10 |
Marinus Pharmaceuticals (MRNS) announces that it has satisfied the FDA's questions regarding the protocol of a Phase 3 clinical trial, RAISE, evaluating intravenous ((IV)) ganaxolone in patients with an extremely severe and life-threatening type of epilepsy called refractory status epilepticu...
Marinus has satisfied the FDA’s protocol-specific questions for the Phase 3 trial in refractory status epilepticus (RSE) Company intends to begin enrollment for registrational Phase 3 clinical trial in RSE; over 55 out of projected 80 sites have been selected for trial part...
Arbutus reports positive data for AB-729 for chronic hepatitis B. Marinus Pharmaceuticals hits primary endpoint in the Genetic Epilepsy trial. Novus Therapeutics on upswing on Anelixis acquisition. For further details see: Arbutus Reports Positive Hepatitis B Data, And O...
Marinus Pharmaceuticals (MRNS) will effect a 1:4 reverse stock split of its common stock today at 5:00 pm ET.The company’s common stock will trade on The Nasdaq Global Market on a split-adjusted basis under a new CUSIP number 56854Q200 on September 23, 2020. The reverse stock split wil...
- Shares of Common Stock Will Begin Trading on Split-Adjusted Basis on September 23, 2020 Marinus Pharmaceuticals, Inc . (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced that it ...
Dozens of healthcare stocks grew by double-digit percentages last week, and shares of these three drugmakers rose further than nearly all of their peers. Clinical trial results, coronavirus vaccine progress, and a buyout were the major factors that turned these biotech stocks into big gainers la...
Novus Therapeutics (NASDAQ: NVUS ) -17% . More news on: Novus Therapeutics, Inc., Nano-X Imaging Ltd., Plus Therapeutics, Inc., Stocks on the move, , Read more ...
Gainers: Novus Therapeutics (NASDAQ: NVUS ) +162% . More news on: Novus Therapeutics, Inc., Marinus Pharmaceuticals, Inc., Plus Therapeutics, Inc., Stocks on the move, , Read more ...
4 Penny Stocks To Buy Right Now According To Analysts Whether you buy penny stocks because of analysts or simply use ratings in your overall strategy, it helps to get a full lay of the land. What I mean by this is that most retail traders will look at a few facets of certain companies. They...
Many investors have been worried about the Nasdaq Composite (NASDAQINDEX: ^IXIC) lately. The index has taken a leadership role during 2020's huge rebound from the coronavirus bear market, but its steep decline in early September made some believe that the best of times for the Nasdaq were no...
News, Short Squeeze, Breakout and More Instantly...
Marinus Pharmaceuticals Inc. Company Name:
MRNS Stock Symbol:
NASDAQ Market:
Marinus Pharmaceuticals Inc. Website:
Marinus Pharmaceuticals , Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it plans to release financial results for the second quarter ended June 30, 2024 on August 13, 2024. The Company will h...
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Lawsuit Filed by the Schall Law Firm PR Newswire LOS ANGELES , July 24, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing ...
Marinus Pharmaceuticals , Inc. (Nasdaq:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that the China National Medical Products Administration (NMPA) has approved ganaxolone oral suspension for the treatment of ...